Scientists identify method to study resilience to pain
Scientists at the Yale School of Medicine and Veterans Affairs Connecticut Healthcare System have successfully demonstrated that it is possible to pinpoint genes that contribute to inter-individual differences in pain.
Chinas Demand for $17,000 Gene-Altered Lab Mice Is Skyrocketing
Sacks of pungent animal feed cram the corridors of a Cyagen Biosciences Inc. center for laboratory mice in southern China, maximizing space for rodents that sell for as much as $17,000 a pair.
CAR T-cell cancer therapy approved for use in Japan, offering new hope for young leukemia patients
An expert panel of the health ministry on Wednesday approved production and sales of a chimeric antigen receptor T-cell cancer therapy, which gives hope to young leukemia patients who cannot be cured with existing anti-cancer agents.
Brexit’s impact on gene and cell therapy research
Development of gene and cell therapies focused on treating, and possibly curing, the neediest of more than 1.5 billon individuals who have mutations linked to genetic diseases has been a priority for the Horizon 2020 project. Additional funding is likely with Horizon Europe, which currently has €8.2 billion earmarked for health research.
Discovery of the genetic conductor of brain stem cells
Our brain comprises 85 billion nerve cells and just as many so-called glial cells, which work in close contact with the former to guarantee their proper function.
Potential new treatment for heart attack
Scientists have found a potential new drug for treating the heart damage caused by a heart attack by targeting the way the heart reacts to stress, according to new research published in the journal, Cell Stem Cell and part-funded by the British Heart Foundation (BHF).
Fujifilm Corporation (has announced it has agreed to acquire Biogen Manufacturing ApS for approximately US$890 million
Acting FDA Commissioner named as Ned SharplessFujifilm will acquire Biogen manufacturing facility to accelerate CDMO growthNational MS Society commits US$1 million for phase II stem cell trial.
Center for Gene and Cell Therapy Co-founded by Miltenyi and ATLATL in Shanghai
To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center for Gene and Cell Therapy.
"Technology and Innovation Ecosystem" is a bud for scenting the time of Iran and Iranians
The Vice President of Science and Technology, in a congratulatory message on the beginning of 1398, emphasized: "Technology and Innovation Ecosystem" is a bud for scenting the time of Iran and Iranians. The ecosystem brings life to all our regions and is full of pure achievements.
President felicitates Nowruz 1398 to heads of regional states
President Rouhani sent separate messages to heads of Afghanistan, Tajikistan, Pakistan, Azerbaijan, Turkmenistan, Armenia, Turkey, Kazakhstan, Kyrgyzstan, Iraq and Uzbekistan to congratulate Nowruz 1398 to them.
